IL234815A0 - Heat-manufactured unbreakable pharmaceutical dosage form containing zinc - Google Patents
Heat-manufactured unbreakable pharmaceutical dosage form containing zincInfo
- Publication number
- IL234815A0 IL234815A0 IL234815A IL23481514A IL234815A0 IL 234815 A0 IL234815 A0 IL 234815A0 IL 234815 A IL234815 A IL 234815A IL 23481514 A IL23481514 A IL 23481514A IL 234815 A0 IL234815 A0 IL 234815A0
- Authority
- IL
- Israel
- Prior art keywords
- thermoformed
- tamper
- dosage form
- pharmaceutical dosage
- containing zinc
- Prior art date
Links
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 title 1
- 239000002552 dosage form Substances 0.000 title 1
- 239000011701 zinc Substances 0.000 title 1
- 229910052725 zinc Inorganic materials 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12003743 | 2012-05-11 | ||
| PCT/EP2013/059728 WO2013167735A1 (en) | 2012-05-11 | 2013-05-10 | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL234815A0 true IL234815A0 (en) | 2014-12-31 |
Family
ID=48407572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL234815A IL234815A0 (en) | 2012-05-11 | 2014-09-23 | Heat-manufactured unbreakable pharmaceutical dosage form containing zinc |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP2846835B1 (OSRAM) |
| JP (2) | JP2015516406A (OSRAM) |
| CN (1) | CN104428002B (OSRAM) |
| AU (1) | AU2013257943B2 (OSRAM) |
| BR (1) | BR112014026768A2 (OSRAM) |
| CA (1) | CA2870012A1 (OSRAM) |
| CY (1) | CY1119637T1 (OSRAM) |
| DK (1) | DK2846835T3 (OSRAM) |
| EA (1) | EA029171B1 (OSRAM) |
| ES (1) | ES2650945T3 (OSRAM) |
| HR (1) | HRP20171718T1 (OSRAM) |
| HU (1) | HUE035123T2 (OSRAM) |
| IL (1) | IL234815A0 (OSRAM) |
| LT (1) | LT2846835T (OSRAM) |
| MX (1) | MX357783B (OSRAM) |
| NO (1) | NO2846835T3 (OSRAM) |
| PL (1) | PL2846835T3 (OSRAM) |
| PT (1) | PT2846835T (OSRAM) |
| RS (1) | RS56685B1 (OSRAM) |
| SI (1) | SI2846835T1 (OSRAM) |
| WO (1) | WO2013167735A1 (OSRAM) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| EP2249811A1 (en) | 2008-01-25 | 2010-11-17 | Grünenthal GmbH | Pharmaceutical dosage form |
| AR077493A1 (es) | 2009-07-22 | 2011-08-31 | Gruenenthal Gmbh | Composicion farmaceutica extruida en caliente con liberacion controlada. procedimiento de preparacion |
| SI2456424T1 (sl) | 2009-07-22 | 2013-10-30 | Gruenenthal Gmbh | Oksidacijsko stabilizirana odmerna oblika, varna pred zlorabo |
| PL2611425T3 (pl) | 2010-09-02 | 2014-09-30 | Gruenenthal Gmbh | Odporna na ingerencję postać dawki zawierająca polimer anionowy |
| MX2013002377A (es) | 2010-09-02 | 2013-04-29 | Gruenenthal Gmbh | Forma de dosificacion resistente a manipulacion que comprende una sal inorganica. |
| EP2736497B1 (en) | 2011-07-29 | 2017-08-23 | Grünenthal GmbH | Tamper-resistant tablet providing immediate drug release |
| JP2014524925A (ja) | 2011-07-29 | 2014-09-25 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 即時薬剤放出を提供するタンパーレジスタント錠剤 |
| MX356421B (es) | 2012-02-28 | 2018-05-29 | Gruenenthal Gmbh | Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico. |
| AR090695A1 (es) | 2012-04-18 | 2014-12-03 | Gruenenthal Gmbh | Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis |
| US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
| US9737490B2 (en) | 2013-05-29 | 2017-08-22 | Grünenthal GmbH | Tamper resistant dosage form with bimodal release profile |
| MX371432B (es) | 2013-05-29 | 2020-01-30 | Gruenenthal Gmbh | Forma de dosificacion resistente al uso indebido que contiene una o mas particulas. |
| EA032465B1 (ru) | 2013-07-12 | 2019-05-31 | Грюненталь Гмбх | Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления |
| BR112016010482B1 (pt) | 2013-11-26 | 2022-11-16 | Grünenthal GmbH | Preparação de uma composição farmacêutica em pó por meio de criomoagem |
| MX2016014738A (es) | 2014-05-12 | 2017-03-06 | Gruenenthal Gmbh | Formulacion en capsula de liberacion inmediata resistente a alteraciones que comprende tapentadol. |
| MX2016015417A (es) | 2014-05-26 | 2017-02-22 | Gruenenthal Gmbh | Multiparticulas protegidas contra vertido de dosis etanolico. |
| EA035434B1 (ru) | 2015-04-24 | 2020-06-15 | Грюненталь Гмбх | Защищенная от применения не по назначению лекарственная форма с немедленным высвобождением и устойчивостью к экстракции растворителями |
| BR112017022846A2 (pt) | 2015-04-24 | 2018-07-17 | Gruenenthal Gmbh | combinação de dose fixa inviolável que proporciona rápida liberação de dois fármacos de partículas diferentes |
| BR112017022856A2 (pt) | 2015-04-24 | 2018-07-17 | Gruenenthal Gmbh | combinação de dose fixa inviolável que proporciona rápida liberação de duas drogas a partir de partículas |
| WO2016170093A1 (en) | 2015-04-24 | 2016-10-27 | Grünenthal GmbH | Tamper-resistant fixed dose combination providing fast release of two drugs from particles and a matrix |
| US11234974B2 (en) | 2015-05-28 | 2022-02-01 | Lumosa Therapeutics Co., Ltd. | Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester |
| US10183018B2 (en) | 2015-05-28 | 2019-01-22 | Lumosa Therapeutics Co., Ltd. | Pharmaceutical formulations for sustained release of sebacoyl dinalbuphine ester |
| WO2017042325A1 (en) | 2015-09-10 | 2017-03-16 | Grünenthal GmbH | Protecting oral overdose with abuse deterrent immediate release formulations |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5082668A (en) | 1983-05-11 | 1992-01-21 | Alza Corporation | Controlled-release system with constant pushing source |
| AU7077287A (en) | 1986-03-31 | 1987-10-08 | Union Carbide Corporation | Alkylene oxide polymerisation catalyst |
| DE3612211A1 (de) | 1986-04-11 | 1987-10-15 | Basf Ag | Kontinuierliches verfahren zum tablettieren |
| US4667013A (en) | 1986-05-02 | 1987-05-19 | Union Carbide Corporation | Process for alkylene oxide polymerization |
| JP3073054B2 (ja) | 1991-07-11 | 2000-08-07 | 住友精化株式会社 | アルキレンオキシド重合体の製造方法 |
| JP2002265592A (ja) | 2001-03-07 | 2002-09-18 | Sumitomo Seika Chem Co Ltd | アルキレンオキシド重合体の製造方法 |
| US7141250B2 (en) | 2001-08-06 | 2006-11-28 | Euro-Celtique S.A. | Pharmaceutical formulation containing bittering agent |
| DE60224293T2 (de) | 2001-09-21 | 2008-12-11 | Egalet A/S | Feste dispersionen mit kontrollierter freisetzung von carvedilol |
| JP4551089B2 (ja) | 2001-10-29 | 2010-09-22 | マサチューセッツ インスティテュート オブ テクノロジー | 三次元印刷により製造されたゼロ次放出プロフィール投薬形態のような徐放投薬形態を製造するためのシステム |
| DE10252667A1 (de) | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
| DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
| US20070183980A1 (en) * | 2003-08-06 | 2007-08-09 | Elisabeth Arkenau-Maric | Dosage form that is safeguarded from abuse |
| DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| US7201920B2 (en) * | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
| DE10360792A1 (de) | 2003-12-23 | 2005-07-28 | Grünenthal GmbH | Spirocyclische Cyclohexan-Derivate |
| EP1740156B8 (de) | 2004-04-22 | 2012-07-11 | Grünenthal GmbH | Verfahren zur herstellung einer gegen missbrauch gesicherten, festen darreinchungsform |
| WO2005105036A1 (en) | 2004-04-28 | 2005-11-10 | Natco Pharma Limited | Controlled release mucoadhesive matrix formulation containing tolterodine and a process for its preparation |
| FI1765303T4 (fi) | 2004-07-01 | 2023-01-31 | Väärinkäytöltä suojattu oraalinen tabletti | |
| AR049839A1 (es) | 2004-07-01 | 2006-09-06 | Gruenenthal Gmbh | Procedimiento para la produccion deuna forma farmaceutica solida, protegida frente al abuso |
| WO2006002886A1 (de) | 2004-07-01 | 2006-01-12 | Grünenthal GmbH | Gegen missbrauch gesicherte, orale darreichungsform enthaltend (1r, 2r)-3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol |
| DE102004032049A1 (de) * | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
| US20060177380A1 (en) | 2004-11-24 | 2006-08-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
| WO2006133733A1 (en) * | 2005-06-13 | 2006-12-21 | Flamel Technologies | Oral dosage form comprising an antimisuse system |
| CA2930487A1 (en) | 2007-01-16 | 2008-07-24 | Egalet Ltd. | Use of i) a polyglycol and ii) an active drug substance for the preparation of a pharmaceutical composition for i)mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse |
| DE102007011485A1 (de) | 2007-03-07 | 2008-09-11 | Grünenthal GmbH | Darreichungsform mit erschwertem Missbrauch |
| EP2155167A2 (en) | 2007-06-04 | 2010-02-24 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
| EP2249811A1 (en) | 2008-01-25 | 2010-11-17 | Grünenthal GmbH | Pharmaceutical dosage form |
| AR074347A1 (es) | 2008-11-14 | 2011-01-12 | Portola Pharm Inc | Composicion solida para liberacion controlada de agentes activos ionizables con solubilidad acuosa deficiente a ph bajo y sus metodos de uso |
| SI2456424T1 (sl) * | 2009-07-22 | 2013-10-30 | Gruenenthal Gmbh | Oksidacijsko stabilizirana odmerna oblika, varna pred zlorabo |
-
2013
- 2013-05-10 PT PT137217667T patent/PT2846835T/pt unknown
- 2013-05-10 HU HUE13721766A patent/HUE035123T2/en unknown
- 2013-05-10 SI SI201330858T patent/SI2846835T1/en unknown
- 2013-05-10 RS RS20171251A patent/RS56685B1/sr unknown
- 2013-05-10 AU AU2013257943A patent/AU2013257943B2/en not_active Ceased
- 2013-05-10 JP JP2015510834A patent/JP2015516406A/ja active Pending
- 2013-05-10 EA EA201401240A patent/EA029171B1/ru not_active IP Right Cessation
- 2013-05-10 MX MX2014013095A patent/MX357783B/es active IP Right Grant
- 2013-05-10 WO PCT/EP2013/059728 patent/WO2013167735A1/en not_active Ceased
- 2013-05-10 ES ES13721766.7T patent/ES2650945T3/es active Active
- 2013-05-10 CA CA2870012A patent/CA2870012A1/en not_active Abandoned
- 2013-05-10 EP EP13721766.7A patent/EP2846835B1/en not_active Not-in-force
- 2013-05-10 CN CN201380024652.2A patent/CN104428002B/zh not_active Expired - Fee Related
- 2013-05-10 BR BR112014026768A patent/BR112014026768A2/pt not_active Application Discontinuation
- 2013-05-10 LT LTEP13721766.7T patent/LT2846835T/lt unknown
- 2013-05-10 DK DK13721766.7T patent/DK2846835T3/en active
- 2013-05-10 PL PL13721766T patent/PL2846835T3/pl unknown
- 2013-05-10 HR HRP20171718TT patent/HRP20171718T1/hr unknown
- 2013-05-10 NO NO13721766A patent/NO2846835T3/no unknown
-
2014
- 2014-09-23 IL IL234815A patent/IL234815A0/en unknown
-
2017
- 2017-11-01 JP JP2017211487A patent/JP6541748B2/ja not_active Expired - Fee Related
- 2017-12-04 CY CY20171101265T patent/CY1119637T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE035123T2 (en) | 2018-05-02 |
| HK1207978A1 (en) | 2016-02-19 |
| ES2650945T3 (es) | 2018-01-23 |
| JP2015516406A (ja) | 2015-06-11 |
| EA029171B1 (ru) | 2018-02-28 |
| CN104428002A (zh) | 2015-03-18 |
| JP2018065810A (ja) | 2018-04-26 |
| LT2846835T (lt) | 2017-12-27 |
| EP2846835A1 (en) | 2015-03-18 |
| EP2846835B1 (en) | 2017-09-06 |
| WO2013167735A1 (en) | 2013-11-14 |
| PL2846835T3 (pl) | 2018-02-28 |
| BR112014026768A2 (pt) | 2017-06-27 |
| DK2846835T3 (en) | 2017-12-04 |
| MX2014013095A (es) | 2014-12-08 |
| JP6541748B2 (ja) | 2019-07-10 |
| RS56685B1 (sr) | 2018-03-30 |
| CY1119637T1 (el) | 2018-04-04 |
| CA2870012A1 (en) | 2013-11-14 |
| AU2013257943A1 (en) | 2014-10-09 |
| NO2846835T3 (OSRAM) | 2018-02-03 |
| PT2846835T (pt) | 2017-12-15 |
| AU2013257943B2 (en) | 2017-10-05 |
| CN104428002B (zh) | 2017-08-11 |
| MX357783B (es) | 2018-07-25 |
| HRP20171718T1 (hr) | 2017-12-29 |
| EA201401240A1 (ru) | 2015-04-30 |
| SI2846835T1 (en) | 2018-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL234815A0 (en) | Heat-manufactured unbreakable pharmaceutical dosage form containing zinc | |
| PL2648699T3 (pl) | Postać dawkowania odporna na manipulację | |
| IL273076A (en) | Solid dosage form | |
| IL235608A (en) | Carriers for improved drug delivery | |
| PL2870072T3 (pl) | Dozownik leków | |
| GB2512800B (en) | One-piece molded auto-refill single dose dispenser | |
| EP2921152A4 (en) | DRUG DELIVERY SYSTEM | |
| IL235131A0 (en) | dispenses medicine | |
| EP2842539A4 (en) | DRUG DELIVERY SYSTEM | |
| ZA201405797B (en) | Pharmaceutical dosage form | |
| GB201205164D0 (en) | Pharmaceutical compounds | |
| EP2841128A4 (en) | PISTON CLOSURES FOR MEDICINAL PACKAGING CAPSULES | |
| GB201220632D0 (en) | Medication container | |
| IL239512A0 (en) | Pharmaceutical compounds | |
| GB201202027D0 (en) | Pharmaceutical compounds | |
| IL220794A (en) | Medication dispenser | |
| SI2908836T1 (sl) | Farmacevtska formulacija, ki vsebuje kurkumin | |
| SG11201405153UA (en) | Medicinal product package | |
| ZA201406407B (en) | Pharmaceutical formulation containing flupirtin | |
| ZA201502354B (en) | Pharmaceutical dosage form | |
| AU348739S (en) | Dosage container | |
| AU348740S (en) | Dosage container | |
| AU348737S (en) | Dosage container | |
| GB201221308D0 (en) | Medicament container | |
| GB201204429D0 (en) | Dose container |